Session and Lecture Proposals Submission
is now Closed!
Call for Session and Lecture Proposals
The International Neuromodulation Society invites members to submit proposals for plenary and breakout lectures for its 14th World Congress, which will take place in Sydney, Australia on 25 – 30 May 2019.
The Congress program, "Neuromodulation: Leading a Global Medical Revolution," will be organized in accordance with EACCME and ACCME guidelines and will further the INS's educational mission to promote improvement in patient health care by providing physicians and allied health care professionals with high quality, evidence-based educational content focusing on advances in the field of neuromodulation; basic, translational and clinical research; new technology; and global health care. The overarching goals are to enhance learners' knowledge, competence and performance to improve patient access, selection, safety and clinical outcomes.
The Biennial Congress Committee will consider basic science, clinical studies and biomedical engineering presentations on neuromodulation for:
• Neurological disorders, including chronic pain and cancer pain;
• Brain disorders, including epilepsy, Parkinson's disease, dystonia, traumatic brain injury, stroke, psychiatric and cognitive disorders, etc.;
• Cardiovascular disorders, including heart failure, angina and peripheral vascular disease;
• Gastrointestinal disorders;
• Pelvic organ motility disorders;
• Systemic disease; and
As well as:
• Mechanisms of action of neuromodulation; and
• Non- and less-invasive neuromodulation.
Note: This is not a call for abstracts. We shall inform you once the abstract submission system has opened; the abstract deadline will be December 3rd, 2018.
We thank you for your consideration and we hope you will participate in the creation of our scientific program.
Looking forward to receiving your proposal,
Marc Russo, MBBS DA FANZCA FFPMANZCA Timothy Deer, MD
INS Congress Chair INS President
Session and Lecture Proposal Instructions
I. Organizer Information
A. The organizer of the proposed session must provide the following:
1) Full name and professional details (title, institution name)
2) Contact information (mailing address, mobile number, email)
3) A current CV
4) Proof of current INS membership
5) Industry relationship / conflict of interest disclosure
Note: Employees of commercial interests (i.e. device or pharmaceutical companies) may not participate in the development or presentation of CME scientific content.
II. Session Details
Plenary lectures and debates shall range from 20 to 30 minutes in length, depending on the number of speakers and format.
Breakout Sessions shall be 90 minutes in length and shall consist of four (4),
15-minute presentations, followed by a 15-minute discussion.
Please provide the following:
A. Proposed session title
B. Session chair's and each speaker's professional and contact details
(full name, degree, title, institution name, city, state/province, country, email, mobile number). Session chair must be an INS member.
C. Title of each speaker's presentation
Please use only generic device and pharmaceutical names in your proposal and avoid the use of company and product names.
D. Brief description of each presentation and the professional practice gap being addressed
A professional practice gap is the difference between actual and ideal knowledge, skills, competence, practice, performance or patient outcomes. When there is a gap or disparity between what the professional is doing or accomplishing compared to what is "achievable on the basis of current professional knowledge," there is a professional practice gap.
Example: The practice gap is the difference between neuromodulation therapies/techniques that are being used on patients with chronic pain and what new therapies/techniques can be applied to improve physicians' skills or competence and patient care for chronic pain.
(Source: ACCME Criteria and ACCME Standards for Commercial Support)
E. Three (3) educational objectives with desired results. Example:
1. Upon completion of the session, delegates will be able to discuss new scientific data and clinical guidelines to improve patient selection and treatment outcomes for neuromodulation.
1. Increased knowledge of the latest scientific data and clinical guidelines to enable clinicians to: make appropriate, informed decisions when selecting patients for neuromodulation therapies; select the proper therapies; and implant and manage the devices to improve treatment outcomes.
F. Two (2) references from current literature to support this topic.
III. Proposals should meet the following criteria:
- All the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.
- The content or format of a CME activity or its related materials must promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
- Presentations must give a balanced view of therapeutic options and may not contain any messaging or logos from commercial interests. Use of generic names will contribute to this impartiality.
- Proposal Review
The INS Executive, Scientific and Biennial Congress, and Education and CME Committees shall conduct a systematic review of each proposal, evaluating the following:
- Originality and Relevance
- Scientific Merit
- Fulfillment of unmet educational need
- Real or perceived commercial bias and presenter conflict of interest
Only complete proposals will be considered. The Executive and Scientific Committees shall select the most highly scored sessions and/or lectures to construct the scientific program. The Biennial Congress, and Education and CME Committees shall review the draft program to identify and resolve any educational gaps and commercial bias in the content prior to finalizing the program with the Executive and Scientific Committees.
Reviewers will be asked to declare their conflicts of interest and to recuse themselves from reviewing the specific proposal(s) for which they have a conflict. (e.g. The reviewer is an author of the proposal, or has consulted for a company whose therapy is the focus of a proposal.)